WithdrawnNot Applicable

Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol

Stopped: Inadequate enrollment

United States0Started 2015-09-01

Plain-language summary

This research study is for patients with adhesive small bowel obstruction (ASBO). ASBO is a condition in which the small intestine gets blocked due to scars called adhesions. To see the blockage, a contrast agent is given and an x-ray is taken of the belly (abdomen). MD Gastroview and omnipaque are two contrast agents that may be given as part of your normal care for ASBO. This study hopes to see if one is better than the other.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Principle diagnosis of adhesive small bowel obstruction Exclusion Criteria: * Evidence of strangulation on initial CT scan leading to emergent operation * Any known allergy to either contrast agent

What they're measuring

Compare average length of stay for patients admitted with ASBO prior to and after implementation of this protocol.

Timeframe: Three years

Trial details

NCT IDNCT02928458

SponsorThe Guthrie Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-09-13

View on ClinicalTrials.gov More Intestinal Obstruction trials